Disclosure 0000947871-26-000784-1

SEC FORM 4

—

BlossomHill Therapeutics, Inc. (BLSM)

Acquisition (code C) of 1,039,996 shares; price not stated (see filing).

Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VIII LLC · Transaction Code C

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0000947871-26-000784 · filed 2026-08-12 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "BlossomHill Therapeutics, Inc. (BLSM)." Disclosed 2026-08-12. https://desqlong.com/cards/0000947871-26-000784-1 (retrieved 2026-09-26).